66
Participants
Start Date
March 1, 2025
Primary Completion Date
December 1, 2026
Study Completion Date
December 1, 2026
Polyherbal Formulation (PHF)
"Description: A polyherbal formulation with known beneficial effects on gut microbiota and metabolic regulation. The formulation contains selected plant extracts studied for their hypoglycemic, antioxidant, and gut microbiota-modulating properties.~Administration: Oral, daily dosage as per study protocol. Supplier: Arya Vaidya Pharmacy (AVP), Coimbatore, India (GMP-certified)."
Placebo
"Type: Placebo Comparator Description: A placebo formulation that matches PHF in appearance, texture, and administration schedule.~Administration: Oral, daily dosage as per study protocol."
Metformin (Standard Treatment for Type 2 Diabetes)
"Description: Metformin is an FDA and EMA-approved antihyperglycemic medication that improves glycemic control by reducing hepatic glucose production and enhancing insulin sensitivity.~Administration: Oral, per standard dosing guidelines. Availability: Provided to all participants per the national reimbursement scheme for T2D patients in Latvia."
Pauls Stradins Clinical University Hospital, Riga
Pauls Stradins Clinical University Hospital
OTHER